What is Zimmer Biomet Holdings's R&D?

Zimmer Biomet Holdings (ZBH) reported R&D of $103.4M in Q1 2026.

How has Zimmer Biomet Holdings's R&D changed year-over-year?

Zimmer Biomet Holdings's R&D decreased by 6.5% year-over-year, from $110.6M to $103.4M.

What is the long-term trend for Zimmer Biomet Holdings's R&D?

Over 4 years (2021 to 2025), Zimmer Biomet Holdings's R&D has grown at a 1.3% compound annual growth rate (CAGR), from $435.8M to $458.5M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Zimmer Biomet Holdings ZBH R&D

R&D at other companies

StrykerSYK

$413M+2.0%

PDE

Pro-Dex, Inc.PDEX

$827K-12.7%

CONMEDCNMD

$16.33M+26.2%

VericelVCEL

$8.1M+11.6%

ClearPoint NeuroCLPT

$4.52M+33.8%

EnovisENOV

$31.53M+10.5%

Segments

By geography

See full

Americas$71.9M+1.1%

Asia Pacific$3.3M0.0%

EMEA$1.7M-19.0%

Other financials

Income statement

See full

Revenue$2.1B+9.3%

Gross profit$1.5B+11.1%

Operating income$373.2M+27.7%

Net income$238.1M+30.8%

EPS (diluted)$1.22+34.1%

Balance sheet

See full

Cash & equivalents$424.2M-69.4%

Total debt$7.5B+4.1%

Total equity$12.7B+2.2%

Total assets$22.7B+2.4%

Cash flow

See full

Operating cash flow$359.4M-6.1%

CapEx$36.3M-18.6%

Free cash flow$323.1M-4.5%

Valuation

See full

Market cap$17.44B-7.4%

Enterprise value$24.49B-5.2%

P/E22.9×0.0×

P/S2.1×-0.3×

Profitability

See full

Gross margin70%-1.0pp

Operating margin14%-3.0pp

Net margin9.1%-2.8pp

FCF margin17.3%-1.6pp

Returns & leverage

See full

Return on equity6.1%-1.2pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zimmer Biomet Holdings's R&D?: Zimmer Biomet Holdings (ZBH) reported R&D of $103.4M in Q1 2026.
How has Zimmer Biomet Holdings's R&D changed year-over-year?: Zimmer Biomet Holdings's R&D decreased by 6.5% year-over-year, from $110.6M to $103.4M.
What is the long-term trend for Zimmer Biomet Holdings's R&D?: Over 4 years (2021 to 2025), Zimmer Biomet Holdings's R&D has grown at a 1.3% compound annual growth rate (CAGR), from $435.8M to $458.5M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.